Showing results (2501-2510 of 2,553) with videos related to
Sort By:
Pageof 256
Neuro-Oncology Advances|May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessmentMaciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.Cell|January 19, 2024
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspectiveRadhika Mathur, Qixuan Wang, Patrick G Schupp, et al.Nature|February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigensDarwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.Carcinogenesis|July 30, 2010
Inherited variation in immune genes and pathways and glioblastoma riskJudith A Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.BMJ Global Health|January 17, 2023
The creation of the Global Scales for Early Development (GSED) for children aged 0-3 years: combining subject matter expert judgements with big dataGareth McCray, Dana McCoy, Patricia Kariger, et al.Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.Pageof 256